The Impact of Persistently Elevated PSA after Prostatectomy in Men with Recurrent Prostate Cancer in NRG Oncology/RTOG 9601

RTOG 9601 was a randomized trial comparing salvage radiotherapy (SRT) ± anti-androgen therapy (AAT) post-radical prostatectomy (RP). Previous studies have demonstrated a persistently elevated PSA after RP is a poor prognostic feature and that this patient subset may selectively benefit from systemic treatment intensification (NRG GU002). Herein, we aim to investigate the prognostic and/or predictive impact of a persistently elevated PSA post-RP...